Skip to main content

Table 1 Basic information of healthy controls and omicron patients

From: Deciphering the omicron variant: integrated omics analysis reveals critical biomarkers and pathophysiological pathways

 

Healthy controls

Omicron

P

N

15

15

 

Age

49.00 (37.00–61.00)

45.00 (29.00–57.00)

0.578

WBC, 109/L

5.90 (4.80–6.60)

5.33 (4.12–7.17)

0.817

NEU %

58.20 (52.20–62.30)

67.90 (59.20–76.20)

0.024

LYM %

29.80 (27.80–37.60)

18.80 (13.00–30.10)

0.002

MONO %

6.60 (6.40–8.20)

10.10 (8.50–13.70)

0.001

EOS %

3.20 (1.50–4.00)

0.40 (0.30–1.10)

 < 0.001

BASO %

0.13 (0.12–0.23)

0.42 (0.41–0.66)

 < 0.001

NEU, 109/L

3.40 (3.00–3.70)

3.71 (2.59–5.03)

0.380

LYM, 109/L

1.80 (1.60–2.20)

1.30 (0.69–1.39)

 < 0.001

MONO,109/L

0.42 (0.40–0.51)

0.57 (0.42–0.87)

0.040

EOS, 109/L

0.19 (0.16–0.22)

0.02 (0.01–0.06)

 < 0.001

BASO, 10^9/L

0.07 (0.05–0.08)

0.03 (0.02–0.04)

 < 0.001

PT, S

12.80 (12.50–13.50)

12.80 (11.30–15.30)

0.844

INR

0.60 (0.40–0.90)

0.98 (0.85–1.35)

 < 0.001

PTTA, %

96.00 (87.00–106.00)

82.00 (73.00–89.00)

0.004

FIB, g/L

3.22 (2.45–3.26)

3.48 (3.31–3.65)

0.003

APTT, S

33.10 (32.10–36.20)

36.40 (32.20–41.20)

0.171

TT, S

16.20 (15.50–17.80)

17.80 (16.20–18.20)

0.224

D-Dimer, μg/L

333.00 (258.00–364.00)

486.00 (452.00–852.00)

 < 0.001

CRP, mg/dL

2.50 (1.70–3.00)

5.30 (2.82–9.44)

0.005

SAA, mg/L

6.30 (2.90–8.40)

43.60 (29.40–67.60)

 < 0.001

PCT, ng/mL

0.02 (0.01–0.04)

0.09 (0.05–0.14)

 < 0.001

  1. WBC White blood cell, NEU Neutrophil, LYM Lymphocyte, MONO Monocyte, EOS Eosinophils, BASO Basophil, PT Prothrombin time, INR International normalized ratio, PTTA Prothrombin activity, FIB Fibrinogen, APTT Activated partial thromboplastin time, TT Thrombin, DD D-Dimer, CRP C-reactive protein, SAA Serumamyloid A, PCT Procalcitonin